(Q42936555)

11 November 2017

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin (English)

1 reference

11 November 2017

1 reference

Marcos M Lima-Martínez

1

1 reference

11 November 2017

Ernesto Guerra-Alcalá

2

1 reference

11 November 2017

Miguel Contreras

3

1 reference

11 November 2017

José Nastasi

4

1 reference

11 November 2017

Janelle A Noble

5

1 reference

11 November 2017

Constantin Polychronakos

6

1 reference

11 November 2017

1 September 2014

1 reference

Endocrinology, diabetes & metabolism case reports

11 November 2017

1 reference

11 November 2017

2014

1 reference

11 November 2017

140072

1 reference

Next generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

The broad clinical phenotype of Type 1 diabetes at presentation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

New definition for the partial remission period in children and adolescents with type 1 diabetes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

Maturity-onset diabetes of youth in black Americans

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190822

Sitagliptin, a dipeptidyl peptidase-IV inhibitor, improves psoriasis

16 August 2018

1 reference

12 December 2020

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Sitagliptin in glutamic acid decarboxylase antibody-positive diabetes mellitus

1 reference

12 December 2020

Sitagliptin for severe psoriasis

1 reference

12 December 2020

Identifiers

0 references

1 reference

11 November 2017

1 reference